VR Adviser, LLC
- SEC CIK
- 0001615982
- 最新申報
- 2026/8/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/5/14 申報。只含多頭部位。
- 持股檔數
- 28
- 2020 年第 4 季沒有 13F 資料
- 總值
- $9.22 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TILInstil Bio, Inc. | COM | 6,865,076 | $1.72 億 | 18.7% | – | – | 歷史 |
| CNSTConstellation Pharmaceuticals Inc | COM | 4,016,873 | $9,396 萬 | 10.2% | – | – | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 3,720,582 | $9,376 萬 | 10.2% | – | – | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 1,536,193 | $5,097 萬 | 5.5% | – | – | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 3,500,000 | $4,946 萬 | 5.4% | – | – | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,176,145 | $4,901 萬 | 5.3% | – | – | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 1,473,014 | $4,590 萬 | 5.0% | – | – | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 4,040,000 | $4,339 萬 | 4.7% | – | – | – |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 2,641,809 | $4,090 萬 | 4.4% | – | – | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 16,302,596 | $3,473 萬 | 3.8% | – | – | 歷史 |
| LONALeonaBio, Inc. | COM | 1,691,623 | $3,113 萬 | 3.4% | – | – | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 853,206 | $3,004 萬 | 3.3% | – | – | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,240,610 | $2,556 萬 | 2.8% | – | – | 歷史 |
| PHVSPharvaris N.V. | COM | 902,882 | $2,534 萬 | 2.7% | – | – | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 372,306 | $2,292 萬 | 2.5% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 625,754 | $1,818 萬 | 2.0% | – | – | 歷史 |
| KURAKura Oncology, Inc. | COM | 575,000 | $1,626 萬 | 1.8% | – | – | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 591,782 | $1,323 萬 | 1.4% | – | – | 歷史 |
| ACETAdicet Bio, Inc. | COM | 1,000,000 | $1,308 萬 | 1.4% | – | – | 歷史 |
| APTOAptose Biosciences Inc. | COM NEW | 1,605,400 | $959.2 萬 | 1.0% | – | – | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,088,817 | $956.0 萬 | 1.0% | – | – | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 408,377 | $928.6 萬 | 1.0% | – | – | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 700,000 | $711.2 萬 | 0.8% | – | – | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 500,000 | $556.0 萬 | 0.6% | – | – | – |
| MTCRMetacrine, Inc. | COM | 680,000 | $421.6 萬 | 0.5% | – | – | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 85,000 | $370.9 萬 | 0.4% | – | – | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 120,649 | $244.9 萬 | 0.3% | – | – | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 19,495 | $32.6 萬 | <0.1% | – | – | 歷史 |